Tianjin Development HKEX:882:
FY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG PHARMACEUTICAL RMB416.3 MILLION
FY TOTAL OPERATING INCOME FOR TIANJIN LISHENG PHARMACEUTICAL RMB1.39 BILLION
Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
Earlier from Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
- Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
- Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
- Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co